Author： Kalb Paul E.
Publisher： Adis International
ISSN： 1170-7690
Source： PharmacoEconomics, Vol.27, Iss.8, 2009-08, pp. : 623-625
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Off-label drug promotion in the US out of control?
Inpharma, Vol. 1, Iss. 1650, 2008-01 ,pp. :
Access to resources
Recommend
Criminal charges for off-label drug promotion?
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 615, 2010-01 ,pp. :
Rising off-label use of antipsychotics a concern in the US
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 621, 2011-01 ,pp. :
Gabapentin commonly used for off-label indications in the US
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 378, 2002-01 ,pp. :
Rising off-label use of antipsychotics a concern in the US
Reactions Weekly, Vol. 1, Iss. 1336, 2011-01 ,pp. :